搜尋結果
Bayer must face US company's flea and tick drug antitrust lawsuit
Reuters· 3 小時前, opens new tab must face a U.S. antitrust lawsuit accusing a former unit of
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 6 小時前, opens new tab lifted its annual earnings forecast on Wednesday and reported a first-quarter ...
Amgen investors await weight-loss drug data
Reuters· 13 小時前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters· 12 小時前, opens new tab beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand ...
UnitedHealth is not too big to fail, CEO tells Senate panel
Reuters· 6 小時前, opens new tab problems are not a threat to the broader economy, the< ...
Forbes Daily: Weed Stocks Light Up After DEA Reclassification
Forbes· 19 小時前The U.S. Drug Enforcement Administration will end its ban on cannabis ...
At European Conference, Experts Explore What’s Next For Psychedelic Medicine
Forbes· 21 小時前Prior to being approved by the U.S. Food and Drug Administration (FDA), each of those ... ...
The Forgotten Stock Advice That Delivers 170%+ Payout Growth
Forbes· 19 小時前One of the best ways to grab a dividend payer set to surge is a ...
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters· 14 小時前, opens new tab raised its full-year profit forecast on Wednesday on strong demand ...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 12 小時前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ... ...